Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Dose Radiation and Concurrent Carboplatin for Metastatic Medulloblastoma
NCT01542736Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2007
- Primary completion
- Sep 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in medulloblastoma, supratentorial primitive neuroectodermal tumor (sPNET), primitive neuroectodermal tumor (PNET), sponsored by University of Colorado Denver. Started May 2007; status: completed.
02
Drugs
carboplatin
03
Conditions
medulloblastomasupratentorial primitive neuroectodermal tumor (sPNET)primitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT01542736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01542736.